A neuron‐specific Isca1 knockout rat developments multiple mitochondrial dysfunction syndromes
Animal Models and Experimental Medicine · 2023
DOI: 10.1002/ame2.12318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2023. Verfasst von Hanxuan Sheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Peking Union…. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Iron-Sulfur Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Basic Research Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Multiple mitochondrial dysfunction syndromes (MMDS) are rare mitochondrial diseases caused by mutation of mitochondrial iron–sulfur cluster synthesis proteins. This study established a rat model simulating MMDS5 disease in the nervous system to investigate its pathological features and neuronal death.
Methods
We generated neuron‐specific Isca1 knockout rat ( Isca1 flox/flox ‐NeuN‐Cre) using CRISPR‐Cas9 technology. The brain structure changes of CKO rats were studied with MRI, and the behavior abnormalities were analyzed through gait analysis and open field tests, Y maze tests and food maze tests. The pathological changes of neurons were analyzed through H&E staining, Nissl staining, and Golgi staining. Mitochondrial damage was assessed by TEM, western blot and ATP assay, and the morphology of neurons was assessed by WGA immunofluorescence to detect the death of neurons.
Results
This study established the disease model of MMDS5 in the nervous system for the first time, and found that after Isca1 loss, the rats suffered from developmental retardation, epilepsy, memory impairment, massive neuronal death, reduced number of Nissl bodies and dendritic spines, mitochondrial fragmentation, cristae fracture, reduced content of respiratory chain complex protein, and reduced production of ATP. Isca1 knockout caused neuronal oncosis.
Conclusions
This rat model can be used to study the pathogenesis of MMDS. In addition, compared with human MMDS5, the rat model can survive up to 8 weeks of age, effectively extending the window of clinical treatment research, and can be used for the treatment of neurological symptoms in other mitochondrial diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Beijing Engineering Research Center for Experimental Animal Models of Human Diseases, Institute of Laboratory Animal Science, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Hanxuan Sheng, Lianfeng Zhang
Förderung
- National Basic Research Program of China
- National Natural Science Foundation of China
Zitieren
APA
Sheng, H., Lu, D., Qi, X., Ling, Y., Li, J., Zhang, X., Dong, W., Chen, W., Gao, S., Gao, X., Zhang, L., & Zhang, L. (2023). A neuron‐specific Isca1 knockout rat developments multiple mitochondrial dysfunction syndromes. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12318
Vancouver
Sheng H, Lu D, Qi X, Ling Y, Li J, Zhang X, et al. A neuron‐specific Isca1 knockout rat developments multiple mitochondrial dysfunction syndromes. Animal Models and Experimental Medicine. 2023. doi:10.1002/ame2.12318
BibTeX
@article{Sheng2023,
author = {Sheng, Hanxuan and Lu, Dan and Qi, Xiaolong and Ling, Yahao and Li, Jing and Zhang, Xu and Dong, Wei and Chen, Wei and Gao, Shan and Gao, Xiang and Zhang, Li and Zhang, Lianfeng},
title = {A neuron‐specific Isca1 knockout rat developments multiple mitochondrial dysfunction syndromes},
journal = {Animal Models and Experimental Medicine},
year = {2023},
doi = {10.1002/ame2.12318}
}
EUVIMED